Mary Helen Hackney
Impact in
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Global Cancer Incidence and Screening
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 4
- Cancer Risks and Factors 2
-
- Palliative Care and End-of-Life Issues 3
- Co-authors
- Thomas J. Smith (5 shared papers)Laurie W. Cuttino (1 shared paper)Victor Yazbeck (1 shared paper)David A. Gewirtz (1 shared paper)Erin R. Alesi (1 shared paper)Jennifer S. Myers (1 shared paper)Laurie Lyckholm (2 shared papers)Christopher E. Desch (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Clinical Breast Cancer (1 paper)Haemophilia (1 paper)Critical Reviews in Oncology/Hematology (1 paper)Advances in cancer research (1 paper)
- Partner nations
- United StatesPoland
In The Last Decade
Mary Helen Hackney
18 papers receiving 252 citations
Peers
Comparison fields: 5 of 71
- Oncology 76
- Cancer Research 40
- Biomaterials 18
- Hematology 12
- Internal Medicine 3
Countries citing papers authored by Mary Helen Hackney
This map shows the geographic impact of Mary Helen Hackney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Helen Hackney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Helen Hackney more than expected).
Fields of papers citing papers by Mary Helen Hackney
This network shows the impact of papers produced by Mary Helen Hackney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Helen Hackney. The network helps show where Mary Helen Hackney may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary Helen Hackney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 69 | |
| 2 | 2013 | 29 | |
| 3 | 2009 | 23 | |
| 4 | 1996 | 21 | |
| 5 | 1999 | 20 | |
| 6 | 2002 | 18 | |
| 7 | 2001 | 16 | |
| 8 | 1997 | 15 | |
| 9 | 2021 | 14 | |
| 10 | 2007 | 12 | |
| 11 | 2014 | 6 | |
| 12 | 2008 | 6 | |
| 13 | 2023 | 2 | |
| 14 | 2024 | 2 | |
| 15 | 2022 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2017 | 1 | |
| 18 | Cortisol and testosterone responses to training and competition stress in ice-dance skaters a case study | 2002 | 1 |
| 19 | 2024 | 0 | |
| 20 | 2022 | 0 |
About Mary Helen Hackney
Mary Helen Hackney is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Cancer Research, having authored 21 papers that have together received 257 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Palliative Care and End-of-Life Issues (3 papers), Cardiac Imaging and Diagnostics (3 papers), Pain Management and Opioid Use (2 papers), Estrogen and related hormone effects (2 papers) and Cancer Risks and Factors (2 papers). The work is most often cited by research in Oncology (76 citations), Cancer Research (40 citations), Biomaterials (18 citations), Hematology (12 citations) and Internal Medicine (3 citations). Mary Helen Hackney has collaborated with scholars based in United States and Poland. Frequent co-authors include Thomas J. Smith, Laurie W. Cuttino, Victor Yazbeck, David A. Gewirtz, Erin R. Alesi, Jennifer S. Myers, Laurie Lyckholm, Christopher E. Desch, James E. Shaw and Alison Conlin. Their work appears in journals such as Journal of Clinical Oncology, Clinical Breast Cancer, Haemophilia, Critical Reviews in Oncology/Hematology and Advances in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.